Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MD BOLIGUTVIKLING AS
AS
Active
Org 828691082
Påls Vei 5B, 8008 Bodø
Construction of residential and non-residential buildings · NACE 4100
Est. 2022
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 4,9M
+47% vs 2023
EBITDA margin
-42.8%
-172% vs 2023
Equity ratio
-17.5%
Financial strength
Net profit 2024
NOK -3,1M
-330% vs 2023
EBITDA — year on year
NOK millions
4M
2M
1M
-1M
-3M
0M
2022
3M
+300%
2023
-2M
-167%
2024
Key figures
Annual report 2024
Revenue
NOK 4,9M
+47%
EBITDA
NOK -2,1M
-172%
Net profit
NOK -3,1M
-330%
Total assets
NOK 13,1M
-31%
Equity
NOK -2,3M
-373%
Employees
0
—
Company information
Legal name
MD BOLIGUTVIKLING AS
Org number
828691082
Legal form
Aksjeselskap
NACE code
4100 · Construction of residential and non-residential buildings
Founded
9. februar 2022
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Entreprenør virksomhet, oppsett av nybygg, kjøp og salg av fast eiendom.
Contact
Address
Påls Vei 5B, 8008 Bodø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Construction of residential and non-residential buildings
Companies in Bodø
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
0M
2022
3M
2023
5M
2024
EBITDA
NOK millions
0M
1M
2M
3M
3M
0M
2022
3M
2023
-2M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
3 356
4 919
Staff expenses
−0
−0
−0
EBITDA
−6
2 929
−2 103
Depreciation & amort.
−0
−0
−0
EBIT
−6
2 929
−2 103
Net financials
−543
−1 330
−1 040
Profit before tax
−549
1 598
−3 143
Tax
−0
231
−0
Net profit
−549
1 368
−3 143
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
13 996
19 060
13 117
Equity
−525
843
−2 300
Long-term debt
14 202
15 952
13 359
Short-term debt
319
2 265
2 058
Total debt
14 520
18 217
15 417
Financial ratios
5-year trend
EBITDA margin
-42.8%
This company
15.8%
Market median
-371% vs market
2022
2024
Equity ratio
-17.5%
This company
38.2%
Market median
-146% vs market
2022
2024
Return on equity
-314257500.0%
This company
18.4%
Market median
-1707921296% vs market
2022
2024
Net profit margin
-63.9%
This company
8.1%
Market median
-889% vs market
2022
2024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
2022
2024
Debt / equity
6.70×
This company
0.62×
Market median
-981% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-03 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
DE
Daniel Eriksen
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MA
Martin Antonsen
Chairman
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Mamama As
Company
50%
50%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Mamama As
MD BOLIGUTVIKLING AS
(this company)
FJELLSTUA UTVIKLING AS
Board network connections
Board members of MD BOLIGUTVIKLING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Daniel Eriksen
Chief Executive Officer
0 companies
Martin Antonsen
Chairman
0 companies